Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX), a biopharmaceutical company, is committed to discovering, developing and commercializing superior cancer therapeutics. The company’s proprietary platform, AvalonRx®, is designed to discover and develop therapeutics for pathways that have been characterized as “undruggable” in the past. For further information, visit the Company’s web site at www.avalonrx.com.
- 16 years ago
QualityStocks
Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Leading Hospitality Tech Revolution with Innovative Solutions
Nightfood Holdings (OTCQB: NGTF) is modernizing the hospitality industry with its AI-driven robotics solutions and innovative…
-
QualityStocksNewsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Vision in Action: Building the Grid of Tomorrow
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a…
-
QualityStocksNewsBreaks – ROTH Conference Marks a Quarter-Century of Community in Dana Point
The 37th Annual ROTH Conference drew thousands of participants from around the globe to Dana…